Maxim Group Maintains Buy Rating for Immutep: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
Maxim Group has maintained its Buy rating for Immutep (NASDAQ:IMMP) and raised its price target from $8.00 to $10.00. Immutep shares are trading up 4.64% at $2.74 per share, and a move to $10.00 would represent a 264.76% increase.
May 18, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Maxim Group maintains Buy rating for Immutep and raises price target from $8.00 to $10.00. Shares are trading up 4.64% at $2.74.
The maintained Buy rating and increased price target by Maxim Group for Immutep is a positive signal for the stock. This news is likely to attract more investors, driving the stock price up in the short term. The 4.64% increase in share price over the last 24 hours also indicates a positive market reaction to the news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100